Deutetrabenazine in Tics Associated with Tourette Syndrome

BACKGROUND: Deutetrabenazine, an inhibitor of vesicular monoamine transporter type 2 (VMAT2) depletes presynaptic dopamine and is useful in the treatment of hyperkinetic movement disorders. This study explored the safety, tolerability, and preliminary efficacy of deutetrabenazine in adolescents with...

Descripción completa

Detalles Bibliográficos
Autores principales: Jankovic, Joseph, Jimenez-Shahed, Joohi, Budman, Cathy, Coffey, Barbara, Murphy, Tanya, Shprecher, David, Stamler, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia University Libraries/Information Services 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133390/
https://www.ncbi.nlm.nih.gov/pubmed/27917309
http://dx.doi.org/10.7916/D8M32W3H

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133390/
https://www.ncbi.nlm.nih.gov/pubmed/27917309
http://dx.doi.org/10.7916/D8M32W3H

Ejemplares similares